| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NF-kappa B | 5 | 2017 | 355 | 1.240 |
Why?
|
| Colonic Neoplasms | 3 | 2017 | 223 | 1.230 |
Why?
|
| Indoles | 3 | 2017 | 178 | 1.010 |
Why?
|
| Cell Cycle | 7 | 2017 | 348 | 1.000 |
Why?
|
| Food Microbiology | 4 | 2025 | 38 | 0.900 |
Why?
|
| Food Contamination | 2 | 2013 | 55 | 0.780 |
Why?
|
| Camptothecin | 3 | 2017 | 24 | 0.760 |
Why?
|
| DNA Damage | 3 | 2012 | 358 | 0.760 |
Why?
|
| Swine Diseases | 1 | 2022 | 9 | 0.750 |
Why?
|
| Deer | 1 | 2022 | 16 | 0.750 |
Why?
|
| Rodent Diseases | 1 | 2022 | 13 | 0.750 |
Why?
|
| Cattle Diseases | 1 | 2022 | 30 | 0.740 |
Why?
|
| Dog Diseases | 1 | 2022 | 48 | 0.730 |
Why?
|
| Ictaluridae | 3 | 2025 | 8 | 0.690 |
Why?
|
| Signal Transduction | 6 | 2017 | 2111 | 0.680 |
Why?
|
| Quercetin | 2 | 2012 | 46 | 0.670 |
Why?
|
| Neoplasms | 3 | 2024 | 1341 | 0.630 |
Why?
|
| Colorectal Neoplasms | 5 | 2021 | 502 | 0.570 |
Why?
|
| Cell Death | 2 | 2017 | 277 | 0.520 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 979 | 0.500 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2025 | 88 | 0.490 |
Why?
|
| DNA, Bacterial | 2 | 2013 | 207 | 0.480 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 379 | 0.470 |
Why?
|
| Inhibitor of Apoptosis Proteins | 5 | 2012 | 34 | 0.470 |
Why?
|
| Apoptosis | 8 | 2017 | 1541 | 0.450 |
Why?
|
| Skin | 2 | 2025 | 185 | 0.430 |
Why?
|
| Bacteria, Aerobic | 1 | 2013 | 7 | 0.420 |
Why?
|
| Meat Products | 1 | 2013 | 5 | 0.420 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2012 | 233 | 0.420 |
Why?
|
| Caspases | 5 | 2017 | 148 | 0.410 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 454 | 0.380 |
Why?
|
| Cell Line, Tumor | 8 | 2017 | 2598 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 4 | 2025 | 415 | 0.370 |
Why?
|
| Cell Proliferation | 4 | 2021 | 1420 | 0.360 |
Why?
|
| Plant Extracts | 2 | 2013 | 303 | 0.350 |
Why?
|
| Ruta | 1 | 2011 | 3 | 0.350 |
Why?
|
| Nocodazole | 1 | 2010 | 8 | 0.320 |
Why?
|
| Tubulin Modulators | 1 | 2010 | 18 | 0.320 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 209 | 0.320 |
Why?
|
| Paclitaxel | 1 | 2010 | 64 | 0.310 |
Why?
|
| Genome, Bacterial | 2 | 2025 | 132 | 0.300 |
Why?
|
| Bacteria | 1 | 2012 | 285 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 297 | 0.290 |
Why?
|
| Antioxidants | 1 | 2012 | 439 | 0.280 |
Why?
|
| Proteins | 4 | 2005 | 383 | 0.280 |
Why?
|
| G2 Phase | 3 | 2010 | 29 | 0.280 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 134 | 0.280 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2006 | 201 | 0.280 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2005 | 90 | 0.280 |
Why?
|
| Mutation | 4 | 2021 | 1169 | 0.280 |
Why?
|
| Humans | 23 | 2025 | 42163 | 0.270 |
Why?
|
| TNF Receptor-Associated Factor 2 | 2 | 2007 | 16 | 0.260 |
Why?
|
| Phylogeny | 3 | 2025 | 740 | 0.260 |
Why?
|
| Ubiquitin | 2 | 2005 | 80 | 0.240 |
Why?
|
| Animals | 15 | 2025 | 16695 | 0.240 |
Why?
|
| Enterococcus | 1 | 2025 | 8 | 0.240 |
Why?
|
| Aeromonas hydrophila | 1 | 2025 | 4 | 0.240 |
Why?
|
| Fish Diseases | 1 | 2025 | 8 | 0.240 |
Why?
|
| Campylobacter | 1 | 2025 | 2 | 0.240 |
Why?
|
| Campylobacter Infections | 1 | 2025 | 8 | 0.230 |
Why?
|
| Salmonella | 1 | 2025 | 12 | 0.230 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 1068 | 0.230 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2025 | 28 | 0.230 |
Why?
|
| Genomics | 2 | 2025 | 289 | 0.230 |
Why?
|
| HCT116 Cells | 2 | 2015 | 40 | 0.230 |
Why?
|
| Mitosis | 2 | 2005 | 112 | 0.230 |
Why?
|
| Mitochondrial Proteins | 1 | 2005 | 112 | 0.230 |
Why?
|
| Cell Nucleus | 2 | 2017 | 383 | 0.220 |
Why?
|
| Meat | 1 | 2025 | 46 | 0.220 |
Why?
|
| Drug Synergism | 2 | 2017 | 189 | 0.220 |
Why?
|
| Hydrogen Sulfide | 1 | 2025 | 77 | 0.210 |
Why?
|
| Virulence Factors | 1 | 2025 | 119 | 0.210 |
Why?
|
| Staphylococcus aureus | 1 | 2025 | 91 | 0.210 |
Why?
|
| Fluorouracil | 2 | 2014 | 46 | 0.200 |
Why?
|
| Infectious Disease Medicine | 1 | 2022 | 3 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 933 | 0.190 |
Why?
|
| Cattle | 2 | 2022 | 505 | 0.190 |
Why?
|
| DNA Primers | 2 | 2013 | 295 | 0.190 |
Why?
|
| Ferrets | 1 | 2022 | 14 | 0.190 |
Why?
|
| Protein Kinases | 1 | 2002 | 100 | 0.180 |
Why?
|
| Genes, APC | 1 | 2021 | 15 | 0.180 |
Why?
|
| Mitochondria | 1 | 2005 | 516 | 0.180 |
Why?
|
| Rabbits | 1 | 2022 | 292 | 0.180 |
Why?
|
| Tumor Stem Cell Assay | 2 | 2012 | 32 | 0.180 |
Why?
|
| Dogs | 1 | 2022 | 201 | 0.180 |
Why?
|
| Swine | 1 | 2022 | 205 | 0.180 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 602 | 0.170 |
Why?
|
| Cyclin B1 | 2 | 2012 | 18 | 0.170 |
Why?
|
| Mice | 5 | 2022 | 6490 | 0.170 |
Why?
|
| Escherichia coli | 1 | 2023 | 461 | 0.170 |
Why?
|
| Time Factors | 3 | 2017 | 1848 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 165 | 0.170 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 158 | 0.160 |
Why?
|
| Cytokines | 1 | 2024 | 661 | 0.160 |
Why?
|
| Flow Cytometry | 2 | 2012 | 411 | 0.160 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2025 | 232 | 0.160 |
Why?
|
| bcl-X Protein | 2 | 2017 | 27 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 1058 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2012 | 884 | 0.150 |
Why?
|
| Enzyme Activation | 3 | 2011 | 462 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 1112 | 0.140 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2012 | 56 | 0.140 |
Why?
|
| Chemoprevention | 1 | 2017 | 41 | 0.140 |
Why?
|
| Loss of Heterozygosity | 1 | 2017 | 19 | 0.130 |
Why?
|
| Smad4 Protein | 1 | 2017 | 8 | 0.130 |
Why?
|
| Polyesters | 1 | 2017 | 26 | 0.130 |
Why?
|
| Nanocomposites | 1 | 2017 | 23 | 0.130 |
Why?
|
| Egg Shell | 1 | 2017 | 35 | 0.130 |
Why?
|
| Silver | 1 | 2017 | 61 | 0.120 |
Why?
|
| Receptors, Steroid | 2 | 2014 | 37 | 0.120 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1559 | 0.120 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 233 | 0.120 |
Why?
|
| Rats | 2 | 2022 | 3701 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 506 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2021 | 467 | 0.120 |
Why?
|
| Minority Groups | 1 | 2021 | 663 | 0.120 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 58 | 0.120 |
Why?
|
| DNA, Neoplasm | 2 | 2017 | 92 | 0.120 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 62 | 0.120 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2014 | 20 | 0.110 |
Why?
|
| Phleomycins | 1 | 2014 | 2 | 0.110 |
Why?
|
| Organoplatinum Compounds | 1 | 2014 | 18 | 0.110 |
Why?
|
| Sex Ratio | 1 | 2014 | 4 | 0.110 |
Why?
|
| Quinazolines | 1 | 2014 | 37 | 0.110 |
Why?
|
| Gene Amplification | 1 | 2013 | 23 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2012 | 76 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 339 | 0.100 |
Why?
|
| Withania | 1 | 2013 | 6 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 69 | 0.100 |
Why?
|
| Phytotherapy | 1 | 2013 | 78 | 0.100 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 1066 | 0.090 |
Why?
|
| Bioterrorism | 1 | 2012 | 20 | 0.090 |
Why?
|
| Caspase 3 | 2 | 2011 | 226 | 0.090 |
Why?
|
| Etoposide | 1 | 2012 | 21 | 0.090 |
Why?
|
| Microsatellite Repeats | 1 | 2012 | 60 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 177 | 0.090 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 3 | 2005 | 10 | 0.090 |
Why?
|
| Immunoblotting | 3 | 2007 | 181 | 0.090 |
Why?
|
| Cell Movement | 1 | 2015 | 640 | 0.090 |
Why?
|
| Cell Line | 4 | 2014 | 1416 | 0.090 |
Why?
|
| Plant Roots | 1 | 2013 | 180 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 196 | 0.080 |
Why?
|
| Plants, Medicinal | 1 | 2011 | 60 | 0.080 |
Why?
|
| Food-Drug Interactions | 1 | 2010 | 4 | 0.080 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 53 | 0.080 |
Why?
|
| Transfection | 3 | 2005 | 526 | 0.080 |
Why?
|
| Tubulin | 1 | 2010 | 94 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 287 | 0.080 |
Why?
|
| Cell Survival | 2 | 2010 | 934 | 0.080 |
Why?
|
| Microtubules | 1 | 2010 | 120 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2010 | 237 | 0.070 |
Why?
|
| Glutathione Transferase | 2 | 2005 | 90 | 0.070 |
Why?
|
| Male | 5 | 2017 | 22779 | 0.070 |
Why?
|
| Zebrafish Proteins | 1 | 2007 | 55 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2005 | 522 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2006 | 49 | 0.060 |
Why?
|
| Aquaculture | 1 | 2025 | 5 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 261 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2005 | 92 | 0.060 |
Why?
|
| Alabama | 1 | 2025 | 52 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 128 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2005 | 148 | 0.060 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2025 | 34 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 271 | 0.060 |
Why?
|
| Culture Media | 1 | 2025 | 96 | 0.060 |
Why?
|
| Cell Fractionation | 1 | 2005 | 30 | 0.060 |
Why?
|
| Protein Binding | 2 | 2005 | 1076 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2025 | 146 | 0.060 |
Why?
|
| Plasmids | 1 | 2005 | 247 | 0.060 |
Why?
|
| Phenylurea Compounds | 1 | 2004 | 18 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 427 | 0.060 |
Why?
|
| Reference Values | 1 | 2005 | 207 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 160 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2005 | 420 | 0.050 |
Why?
|
| Retraction of Publication as Topic | 1 | 2004 | 2 | 0.050 |
Why?
|
| Virulence | 1 | 2025 | 238 | 0.050 |
Why?
|
| Cell Division | 1 | 2005 | 314 | 0.050 |
Why?
|
| Sulfisoxazole | 1 | 2023 | 1 | 0.050 |
Why?
|
| Nalidixic Acid | 1 | 2023 | 2 | 0.050 |
Why?
|
| Chloramphenicol | 1 | 2023 | 5 | 0.050 |
Why?
|
| Ampicillin | 1 | 2023 | 7 | 0.050 |
Why?
|
| Azithromycin | 1 | 2023 | 6 | 0.050 |
Why?
|
| Tetracycline | 1 | 2023 | 17 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2004 | 228 | 0.050 |
Why?
|
| Chickens | 1 | 2025 | 148 | 0.050 |
Why?
|
| Hela Cells | 1 | 2005 | 370 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 366 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1188 | 0.050 |
Why?
|
| Genotype | 1 | 2025 | 796 | 0.050 |
Why?
|
| Exonucleases | 1 | 2002 | 3 | 0.050 |
Why?
|
| Phenotype | 1 | 2025 | 774 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2002 | 11 | 0.050 |
Why?
|
| Female | 5 | 2017 | 24018 | 0.050 |
Why?
|
| Cyclins | 1 | 2002 | 37 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2021 | 1010 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2005 | 875 | 0.050 |
Why?
|
| Prognosis | 2 | 2017 | 850 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 118 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 30 | 0.050 |
Why?
|
| HT29 Cells | 1 | 2021 | 60 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2021 | 32 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 98 | 0.040 |
Why?
|
| Maryland | 1 | 2021 | 61 | 0.040 |
Why?
|
| Research Personnel | 1 | 2021 | 191 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1679 | 0.040 |
Why?
|
| Disease Progression | 1 | 2021 | 661 | 0.040 |
Why?
|
| Models, Biological | 1 | 2002 | 711 | 0.040 |
Why?
|
| Lignans | 1 | 2017 | 22 | 0.030 |
Why?
|
| Food Packaging | 1 | 2017 | 5 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2017 | 12 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2017 | 27 | 0.030 |
Why?
|
| Stilbenes | 1 | 2017 | 44 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2017 | 66 | 0.030 |
Why?
|
| Flavonoids | 1 | 2017 | 94 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2017 | 154 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1804 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 353 | 0.030 |
Why?
|
| Transgenes | 2 | 2007 | 65 | 0.030 |
Why?
|
| Caspase 9 | 2 | 2004 | 30 | 0.030 |
Why?
|
| Insemination, Artificial | 1 | 2014 | 10 | 0.030 |
Why?
|
| Ethiopia | 1 | 2014 | 15 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2014 | 79 | 0.030 |
Why?
|
| Breeding | 1 | 2014 | 28 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1051 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 131 | 0.030 |
Why?
|
| RNA Interference | 1 | 2014 | 246 | 0.030 |
Why?
|
| Methylnitrosourea | 1 | 2013 | 2 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 2013 | 14 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 111 | 0.020 |
Why?
|
| Fibroblasts | 2 | 2004 | 278 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 587 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 436 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 293 | 0.020 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2012 | 1 | 0.020 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2012 | 2 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 534 | 0.020 |
Why?
|
| Fucosyltransferases | 1 | 2012 | 9 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2012 | 25 | 0.020 |
Why?
|
| Aged | 2 | 2017 | 7982 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 72 | 0.020 |
Why?
|
| Microsatellite Instability | 1 | 2012 | 47 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 426 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 310 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 382 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 557 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 1737 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2007 | 18 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 22 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 134 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2012 | 722 | 0.020 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2006 | 9 | 0.020 |
Why?
|
| Homeostasis | 1 | 2007 | 193 | 0.020 |
Why?
|
| Zebrafish | 1 | 2007 | 146 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 2803 | 0.010 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2004 | 4 | 0.010 |
Why?
|
| Indenes | 1 | 2004 | 4 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2004 | 22 | 0.010 |
Why?
|
| Baculoviridae | 1 | 2004 | 14 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 51 | 0.010 |
Why?
|
| Serpins | 1 | 2004 | 29 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 69 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 64 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 221 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 152 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2004 | 95 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2004 | 115 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 1617 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2004 | 196 | 0.010 |
Why?
|
| Ecdysone | 1 | 2002 | 7 | 0.010 |
Why?
|
| Exoribonucleases | 1 | 2002 | 10 | 0.010 |
Why?
|
| 14-3-3 Proteins | 1 | 2002 | 22 | 0.010 |
Why?
|
| G1 Phase | 1 | 2002 | 33 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2002 | 40 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2002 | 23 | 0.010 |
Why?
|
| Genes, p53 | 1 | 2002 | 28 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 658 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 279 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 548 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 222 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 239 | 0.010 |
Why?
|
| Kidney | 1 | 2002 | 363 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 11819 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 13458 | 0.010 |
Why?
|